abs376.txt	breast	cancers	detected	after	a	negative	breast	screening	examination	and	priorto	the	next	screening	are	referred	to	as	interval	cancers		these	cancersgenerally	have	poor	clinical	characteristics	compared	with	screen-detectedcancers		but	associations	between	interval	cancer	and	genomic	cancercharacteristics	are	not	well	understood		mammographically	screened	womendiagnosed	with	primary	invasive	breast	cancer	from	1993	to	2013	(n	=	370)	wereidentified	by	linking	the	carolina	breast	cancer	study	and	the	carolinamammography	registry		among	women	with	a	registry-identified	screening	mammogram0	to	24	months	before	diagnosis		cancers	were	classified	as	screen-detected	(n	=165)	or	interval-detected	(n	=	205)		using	logistic	regression		we	examined	theassociation	of	mode	of	detection	with	cancer	characteristics	(clinical		ihc		andgenomic)		overall		and	in	analyses	stratified	on	mammographic	density	and	race	interval	cancer	was	associated	with	large	tumors	[>2	cm		or		2	3		95%	confidenceinterval	(ci)		1	5-3	7]		positive	nodal	status	(or		1	8		95%	ci		1	1-2	8)		andtriple-negative	subtype	(or		2	5		95%	ci		1	1-5	5)		interval	cancers	were	morelikely	to	have	non-luminal	a	subtype	(or		2	9		95%	ci		1	5-5	7)		whereasscreen-detected	cancers	tended	to	be	more	indolent	(96%	had	low	risk	ofrecurrence	genomic	scores		71%	were	pam50	luminal	a)		when	stratifying	bymammographic	density	and	race		associations	between	interval	detection	and	poorprognostic	features	were	similar	by	race	and	density	status		strong	associationsbetween	interval	cancers	and	poor-prognosis	genomic	features	(non-luminal	asubtype	and	high	risk	of	recurrence	score)	suggest	that	aggressive	tumor	biologyis	an	important	contributor	to	interval	cancer	rates		cancer	prev	res		11(6)	327-36		Â©2018	aacr	
